AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Lucid Diagnostics Inc. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG012NYMM65
0.41▲ 0.08 (25.42%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.33
Day's Range
0.39 – 0.45
52-Week Range
0.30 – 1.63
Volume
108.3M
Avg Volume
5.7M
Share Statistics
Shares Outstanding
Employees
82
Exchange
XNAS
Listed
2021-10-14
Share count as of August 10, 2026

Lucid Diagnostics Inc. Common Stock (LUCD) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Lucid Diagnostics Inc. Common Stock (LUCD)
What is Lucid Diagnostics Inc. Common Stock's Market Cap?
Lucid Diagnostics Inc. Common Stock's Market Cap is $83.5M, based on as-reported figures from SEC (XBRL) filings.
What is Lucid Diagnostics Inc. Common Stock's Enterprise Value?
Lucid Diagnostics Inc. Common Stock's Enterprise Value is $50.1M, based on as-reported figures from SEC (XBRL) filings.
What is Lucid Diagnostics Inc. Common Stock's Price / Sales?
Lucid Diagnostics Inc. Common Stock's Price / Sales is 15.3×, based on as-reported figures from SEC (XBRL) filings.
What is Lucid Diagnostics Inc. Common Stock's EV / Revenue?
Lucid Diagnostics Inc. Common Stock's EV / Revenue is 9.2×, based on as-reported figures from SEC (XBRL) filings.
What is Lucid Diagnostics Inc. Common Stock's EV / EBITDA?
Lucid Diagnostics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Lucid Diagnostics Inc. Common Stock's Revenue (TTM)?
Lucid Diagnostics Inc. Common Stock's Revenue (TTM) is $5.4M, based on as-reported figures from SEC (XBRL) filings.
What is Lucid Diagnostics Inc. Common Stock's Net Income (TTM)?
Lucid Diagnostics Inc. Common Stock's Net Income (TTM) is -$52.3M, based on as-reported figures from SEC (XBRL) filings.
What is Lucid Diagnostics Inc. Common Stock's EBITDA?
Lucid Diagnostics Inc. Common Stock's EBITDA is -$49.8M, based on as-reported figures from SEC (XBRL) filings.
What is Lucid Diagnostics Inc. Common Stock's Diluted EPS (TTM)?
Lucid Diagnostics Inc. Common Stock's Diluted EPS (TTM) is -0.26, based on as-reported figures from SEC (XBRL) filings.
What is Lucid Diagnostics Inc. Common Stock's EBITDA Margin?
Lucid Diagnostics Inc. Common Stock's EBITDA Margin is -914.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · LUCDAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+26.7%+51.7%+25.6%+3.3%
Operating expenses:
Cost of revenue
Sales and marketing
General and administrative
Amortization of acquired intangible assets
Research and development
Total operating expenses
% of revenue968.5%1064.5%1031.6%1071.0%
Operating loss
% of revenue-868.5%-964.5%-931.6%-971.0%
Other income (expense):
Interest income
Interest expense
Change in fair value - Senior Secured Convertible Note
Other income (expense), net
Loss before provision for income tax
Provision for income taxes——
Net loss attributable to Lucid Diagnostics Inc.
% of revenue-792.9%-1107.4%-1081.5%-858.5%
Less: Series B Convertible Preferred Stock dividends earned——
Net loss attributable to Lucid Diagnostics Inc. common stockholders
Net loss per share attributable to Lucid Diagnostics Inc. common stockholders - basic and diluted (in dollars per share)